MARKET

ABUS

ABUS

Arbutus Biopharm
NASDAQ
4.530
-0.170
-3.62%
After Hours: 4.561 +0.031 +0.68% 18:27 03/06 EST
OPEN
4.590
PREV CLOSE
4.700
HIGH
4.670
LOW
4.460
VOLUME
3.37M
TURNOVER
--
52 WEEK HIGH
5.10
52 WEEK LOW
2.705
MARKET CAP
871.23M
P/E (TTM)
-20.4054
1D
5D
1M
3M
1Y
5Y
1D
Moderna Settles Arbutus Genevant Patent Litigation for $950 Million
Reuters · 3d ago
Notable Wednesday Option Activity: GTLB, ABUS, TTWO
NASDAQ · 4d ago
Midday Fly By: Stocks climb as oil prices pull back
TipRanks · 4d ago
Morning News Wrap-Up 3/4/26: Wednesday’s Biggest Stock Market Stories!
TipRanks · 4d ago
Why Moderna's $950M Patent Bill Is A Small Price For Pipeline Freedom
Seeking Alpha · 4d ago
Unusually active option classes on open March 4th
TipRanks · 4d ago
Moderna gains as Arbutus/ Genevant settlement removes major financial risk
Seeking Alpha · 4d ago
Video: Moderna advances as settlement seen removing share overhang
TipRanks · 4d ago
More
About ABUS
Arbutus Biopharma Corporation is a clinical-stage biopharmaceutical company focused on infectious disease. The Company is developing imdusiran (AB-729), its proprietary, conjugated GalNAc, subcutaneously delivered RNAi therapeutic, and AB-101, its proprietary oral PD-L1 inhibitor, for the treatment of chronic hepatitis B (cHBV). Its HBV product pipeline includes Imdusiran and AB-101. Its pipeline includes two product candidates that target various steps in the HBV viral lifecycle and consists of various programs: RNAi therapeutic (imdusiran, AB-729) and Oral PD-L1 Inhibitor (AB-101). RNAi therapeutics utilize a natural pathway within cells to silence genes by eliminating the disease-causing proteins that they code for. PD-L1 inhibitors complement its pipeline of agents and could potentially be a part of a combination therapy for the treatment of HBV by reawakening the immune system.

Webull offers Arbutus Biopharma Corp stock information, including NASDAQ: ABUS real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ABUS stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading ABUS stock methods without spending real money on the virtual paper trading platform.